Clinical and pathological implications of the presence of MECA-79-expressing tumor cells in pathological stage IA lung adenocarcinoma - Tomohito Saito; Mitsuaki Ishida; Tomoya O. Akama; Shiho Hattori; Natsumi Maru; Takahiro Utsumi; Aki K. Kobayashi; Kento J. Fukumoto; Hiroshi Matsui; Yohei Taniguchi; Yoshinobu Hirose; Katsuyasu Kouda; et al. (PLoS ONE, 2025)